Drug Resistance Updates: Volume 60 to Volume 65

Drug Resistance Updates (DRU) serves as an esteemed scholarly platform, publishing influential and groundbreaking original research, thoughtful commentaries, and expert reviews, focusing on pivotal developments concerning drug resistance in infectious diseases and cancer. It provides a comprehensive outlook on the evolving landscape of drug resistance, presenting insights into novel drugs and strategies formulated to surmount drug resistance, thus, playing a crucial role in the global scientific community’s effort to combat this challenge.

Core Features:

1. Multidisciplinary Insight: DRU provides a cohesive blend of diverse disciplines including molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology, and clinical medicine, fostering a holistic understanding of drug resistance phenomena.
2. Clinical and Basic Research: The journal is a repository of both clinical insights and fundamental research, covering the spectrum from molecular underpinnings to clinical manifestations of drug resistance.
3. Expert Reviews: DRU is enriched with expert reviews, curated by leaders in the field of drug resistance, offering in-depth analyses and perspectives on the latest developments and challenges in overcoming drug resistance.
4. Innovative Strategies: The journal highlights novel strategies and therapeutic avenues to counter drug resistance in infectious diseases and cancer, serving as a guide to emerging trends and solutions in the field.
5. Invigorating Commentaries: The inclusion of insightful commentaries in DRU fosters intellectual discourse and reflection on critical issues and advancements related to drug resistance.

Submission and Review Process:

While the submission of original research articles is welcomed and encouraged, review articles are predominantly contributed by invitees who are recognized authorities in the field of drug resistance. The articles undergo a meticulous review process to ensure the dissemination of high-quality, impactful, and authoritative content.

Objective and Impact:

The prime objective of Drug Resistance Updates is to illuminate the path for scientific exploration by providing a comprehensive perspective on drug resistance challenges in infectious diseases and cancer. The journal’s impactful content instigates innovation and exploration, contributing significantly to the endeavors aimed at understanding and overcoming drug resistance. It acts as a catalyst for researchers, clinicians, pharmacologists, and other healthcare professionals to develop effective strategies and therapeutic interventions to counteract the multidimensional challenges posed by drug resistance.

Conclusion:

Drug Resistance Updates stands at the forefront of scientific discourse on drug resistance, offering a rich tapestry of content that spans across disciplines and bridges the gap between basic research and clinical application. Its commitment to publishing inspiring and authoritative content makes it an invaluable resource for professionals and researchers striving to navigate and contribute to the complex and evolving domain of drug resistance in infectious disease and cancer.

Volume 60: January 2022

Volume 61: March 2022

Volume 62: May 2022

Volume 63: July 2022

Volume 64: September 2022

Volume 65: December 2022